期刊文献+

老年高血压患者脉压与血浆脑钠素的关系 被引量:1

暂未订购
导出
摘要 目的观察老年高血压患者脉压(PP)与血浆脑钠素(BNP)水平的关系,探讨脉压和血浆BNP水平可否作为判断左室功能不全的临床指标。方法用24小时动态血压仪监测74例老年高血压病患者全天平均脉压(ABPP),据ABPP值分两组:(1)PP≥60 mmHg,41例;(2)PP<60 mmHg,33例。采用超声心动图测定反映左室功能不全指标E/A比值和左室射血分数(LVEF);采用美国Triage及其试剂盒快速测定血浆BNP水平,对BNP、PP与LVEF、E/A比值作直线相关分析。结果老年高血压病患者中PP≥60 mmHg组的血浆BNP水平显著高于PP<60 mmHg组(P<0.01),PP与血浆BNP呈显著正相关(r=0.42,P<0.01);PP与E/A比值呈显著负相关(r=-0.67,P<0.01)。结论老年高血压患者PP与血浆BNP水平密切相关,PP和血浆BNP可作为判断左室功能不全的临床指标。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2006年第9期1208-1209,共2页 Chinese Journal of Gerontology
基金 福建省卫生厅青年科研基金资助项目(2003-1-6)
  • 相关文献

参考文献8

  • 1Zannoli R,Schiereck P,Cllleth F,et al.Effects of were relection timing on left ventricular mechanics[J].J Biomech,1999;32(3):249-54.
  • 2Bettencourt P,Ferreira A,Dias P,et al.Evaluation of brain natriuretic peptide in the diagnosis of heart failure.Cardiology,2000;93(1-2):19-25.
  • 3Maier J,Friedl W,Thoas S,et al.Natriuretic peptide in assessment of left-ventricular dysfunction[J].Scand J Clin Lab Invest,1999;59(s230):132-42.
  • 4王迎.慢性心力衰竭患者脑钠素浓度变化的临床价值[J].心脑血管病防治,2004,4(4):35-38. 被引量:14
  • 5Suga SK,Nakao K,Mukogama Y,et al.Receptor selectivity of natruretic peptide family,atrial natriuretic peptide,brain natriuretic peptide and C-type natriuretic peptide[J].Endocrinology,1992;130:229-39.
  • 6Stanley S,Franklin MD,Shehzad A,et al.Is pulse pressure useful inpredicting risk for coronary heart disease? The Framingham Heart Study[J].Circulation,1999;100(4):354-60.
  • 7王宏宇,张维忠,龚兰生,李志明,邱慧丽,范明昌,吴美枝.高血压病大动脉扩张性与左室肥厚关系的探讨[J].中华心血管病杂志,2000,28(3):177-180. 被引量:116
  • 8于军,薛成相,李洪田,陈万强,汤洪.老年高血压病患者高脉压与靶器官损害[J].高血压杂志,2003,11(4):319-322. 被引量:30

二级参考文献16

  • 1[1]Cowie MR,Mendez GF.BNP and congestive heart failure.Prog cardiovasc Dis,2002,44:293-321.
  • 2[3]Luchner A, Stevens TL,Borgeson DD,et a1. Differential atria and ventricular expression of myocardial BNP during evolution of heart failure.Am J Physiol,1998,274:H1684-1689.
  • 3[4]Dickstein K.Natriuretic peptides in detection of heart failure.Lancet,1998,280:i983.
  • 4[5]Clerio A,lervasi G,Ckicca M,et al.Circulating levels of carolac natrluretuc peptides(ANP ant BNP)measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart fdilure.J Endocrinol Invest,1998,21:170-179.
  • 5[6]Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natnuretlc peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunctiOn. Am Heart J,2001,141:367-374.
  • 6Alderman MH. A new model of risk: Implication of increasing pulse pressure and systolic blood pressure on cardiovascular disease[J] .J Hypertens, 1999,17(suppl 5) :S25 - S28.
  • 7Lderman MH.Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment[J].J hypertens, 1998,16:761 - 769.
  • 8Menotti A, Puddu PE, Lanti M.Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study[ J ]. European Heart Journal, 2000, 21 ( 5 ) :365 - 370.
  • 9Stanley S, Franklin MD, Shehzad A, et al. Is pulse pressure useful in predicting risk for coronary heart diseas? The Framingham Heart Study[J ]. Circulation, 1999,100:354 - 360.
  • 10O' rourke M, Frohlich ED. Pulse pressure is this a clinically useful risk factor[J]? Hypertension, 1999,34:372 - 374.

共引文献156

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部